These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 23928245
1. BI-RADS 3 for magnetic resonance imaging. Comstock C, Sung JS. Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):561-70. PubMed ID: 23928245 [Abstract] [Full Text] [Related]
2. Breast Imaging Reporting and Data System category 3 for magnetic resonance imaging. Lee KA. Top Magn Reson Imaging; 2014 Dec; 23(6):337-44. PubMed ID: 25463408 [Abstract] [Full Text] [Related]
3. Updates and revisions to the BI-RADS magnetic resonance imaging lexicon. Edwards SD, Lipson JA, Ikeda DM, Lee JM. Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):483-93. PubMed ID: 23928239 [Abstract] [Full Text] [Related]
4. Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses. Kim SJ, Morris EA, Liberman L, Ballon DJ, La Trenta LR, Hadar O, Abramson A, Dershaw DD. AJR Am J Roentgenol; 2001 Sep; 177(3):551-7. PubMed ID: 11517046 [Abstract] [Full Text] [Related]
6. MR imaging in probably benign lesions (BI-RADS category 3) of the breast. Gökalp G, Topal U. Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732 [Abstract] [Full Text] [Related]
7. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI. Grimm LJ, Anderson AL, Baker JA, Johnson KS, Walsh R, Yoon SC, Ghate SV. AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298 [Abstract] [Full Text] [Related]
11. Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization. Thomassin-Naggara I, Trop I, Chopier J, David J, Lalonde L, Darai E, Rouzier R, Uzan S. Radiology; 2011 Oct; 261(1):69-79. PubMed ID: 21771958 [Abstract] [Full Text] [Related]
12. Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies. Abramovici G, Mainiero MB. Radiology; 2011 Apr; 259(1):85-91. PubMed ID: 21285337 [Abstract] [Full Text] [Related]
13. It is not all in the CAD or BI-RADS. Kelcz F. Eur J Radiol; 2012 Sep; 81 Suppl 1():S76-7. PubMed ID: 23083612 [No Abstract] [Full Text] [Related]
14. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon. Grimm LJ, Anderson AL, Baker JA, Johnson KS, Walsh R, Yoon SC, Ghate SV. AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951 [Abstract] [Full Text] [Related]
16. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI. Strigel RM, Burnside ES, Elezaby M, Fowler AM, Kelcz F, Salkowski LR, DeMartini WB. AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802 [Abstract] [Full Text] [Related]
17. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA. AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110 [Abstract] [Full Text] [Related]
18. BI-RADS decoded: detailed guidance on potentially confusing issues. D'Orsi CJ, Newell MS. Radiol Clin North Am; 2007 Sep; 45(5):751-63, v. PubMed ID: 17888766 [Abstract] [Full Text] [Related]